Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CFRUY | PH |
|---|---|---|
| Price | $21.05 | $975.68 |
| Change today | ▲ 0.81% | ▲ 0.32% |
| Market cap | $122.64B | $123.05B |
| Return, 3 months | -5.2% | +2.1% |
| Return, year to date | +0.3% | +11.7% |
| Return, 1 year | +10.4% | +28.9% |
| P/E (TTM) | 31.0 | 34.3 |
| P/B | 4.6 | 8.0 |
| P/E percentile vs own 5y | – | 79th |
| Dividend yield | 1.92% | 0.76% |
| Revenue growth (YoY, latest qtr) | – | +9.8% |
| Net profit growth (YoY) | – | +18.3% |
| Gross margin | – | 37.7% |
| Operating margin | – | 21.6% |
| Net margin | – | 17.0% |
| Return on equity | – | 25.1% |
| Analyst target vs. price | – | +22.4% |
| Analyst buy share | – | 71% |
| RSI (14) | 43 | 53 |
| 30-day volatility | 24.9% | 21.7% |
| Max drawdown, 1 year | -25.5% | -19.3% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
